5162504 Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients

LNCaP公司 免疫原 抗原 前列腺酸性磷酸酶 单克隆抗体 前列腺 抗体 染色 病理 上皮 前列腺癌 表位 癌症 化学 生物 分子生物学 医学 免疫学 内科学
作者
Julius S. Horoszewicz,E Kawinski,G P Murphy
出处
期刊:Biotechnology Advances [Elsevier]
卷期号:11 (2): 352-352 被引量:100
标识
DOI:10.1016/0734-9750(93)90273-p
摘要

Stable clones of murine hybridomas 7E11-C5 and 9H10-A4 were obtained following immunization with LNCaP cells. The LNCaP cells were isolated from a human prostatic cancer (Ca). Both hybridomas secreted monoclonal antibodies (MoAb) of the IgG1 subclass which were reactive with the insoluble, cytoplasmic, membrane rich fractions of the immunogen. Neither MoAb reacted with the soluble cytosol of LNCaP cells nor with purified human prostatic acid phosphatase (PAP) nor prostate specific antigen (PSA). MoAb 9H10-A4 reactivity was very narrow and limited to the surfaces of LNCaP cells only. MoAb 7E11-C5 specificity was restricted to human prostatic epithelium, both normal and malignant. Except LNCaP, none of the 32 lines of human normal or neoplastic cells reacted with MoAb 7E11-C5. In a survey of frozen sections from 175 human specimens, positive indirect immunoperoxidase staining was limited to epithelium in all 11 specimens of localized and metastatic CaP, 7 benign prostatic hypertrophy (BPH) cases and 7 normal prostates. None of the 26 various nonprostatic tumors nor 120 out of 122 specimens from 28 different normal organs were reactive. Positive staining occurred in 2 out of 14 normal kidneys. Competitive binding with MoAb 7E11-C5 or its F(ab')2 fragments demonstrated the presence of circulating epitope 7E11-C5 in 20 out of 43 sera from CaP patients. Only 3 out of 66 sera from nonprostatic malignancies reacted. None of 30 normal blood donors sera nor 7 BPH sera were positive. Thus, highly significant (p less than 0.0001) association between diagnosed prostatic cancer and circulating molecules expressing the epitope reactive with MoAb 7E11-C5 was established. Significant probability (p less than 0.05) also suggested that patients with positive ELISA test are more likely to be in progression, than those who are negative. These results suggest that this apparently new antigenic marker may be of clinical potential in CaP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
medzhou完成签到,获得积分10
刚刚
tough_cookie完成签到 ,获得积分10
刚刚
汐颜完成签到,获得积分10
1秒前
关键词完成签到,获得积分10
2秒前
jiysh完成签到,获得积分0
2秒前
酸菜萌萌鱼完成签到,获得积分20
2秒前
嗒嗒嗒薇完成签到 ,获得积分10
2秒前
双shuang完成签到,获得积分10
4秒前
TANG完成签到 ,获得积分10
5秒前
糖糖谈糖糖完成签到,获得积分10
7秒前
李健应助mhq采纳,获得10
7秒前
daijk完成签到,获得积分10
7秒前
QQQ完成签到,获得积分10
7秒前
LQS完成签到,获得积分10
8秒前
杨羕完成签到,获得积分10
9秒前
菠萝吹雪完成签到,获得积分10
10秒前
QQQ发布了新的文献求助10
11秒前
洁净之柔完成签到,获得积分10
12秒前
孙某人完成签到 ,获得积分0
13秒前
星梦完成签到,获得积分10
13秒前
啊凡完成签到 ,获得积分10
13秒前
对白完成签到 ,获得积分10
14秒前
14秒前
Wang完成签到,获得积分10
15秒前
hwzhou10完成签到,获得积分10
16秒前
Alan完成签到,获得积分10
16秒前
万能图书馆应助淡定采纳,获得10
17秒前
17秒前
记忆完成签到,获得积分10
19秒前
20秒前
PDIF-CN2完成签到,获得积分10
20秒前
平淡翎完成签到 ,获得积分20
21秒前
kelly完成签到,获得积分10
22秒前
22秒前
mhq发布了新的文献求助10
22秒前
lin完成签到,获得积分10
23秒前
淡淡的若冰应助啊251采纳,获得10
23秒前
Jasper应助刘佳会采纳,获得10
23秒前
24秒前
欢呼菀完成签到 ,获得积分10
25秒前
高分求助中
Evolution 10000
CANCER DISCOVERY癌症研究的新前沿:中国科研领军人物的创新构想 中国专刊 500
Distribution Dependent Stochastic Differential Equations 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
Die Gottesanbeterin: Mantis religiosa: 656 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3158687
求助须知:如何正确求助?哪些是违规求助? 2809923
关于积分的说明 7884302
捐赠科研通 2468638
什么是DOI,文献DOI怎么找? 1314374
科研通“疑难数据库(出版商)”最低求助积分说明 630601
版权声明 602012